Abstract
In addition to lowering blood lipid levels, statins (HMG CoA reductase inhibitors) inhibit platelet aggregation and maintain a favorable balance between prothrombotic and fibrinolytic mechanisms [1]. Perhaps these effects may account for the association of statins with a reduced risk of venous thrombosis [2,3]. Because different statins have different properties [4], the possibility that the risk of venous thrombosis varied by specific statin was also investigated.
Original language | English |
---|---|
Pages (from-to) | 700-701 |
Journal | Journal of thrombosis and haemostasis |
Volume | 2 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2004 |
Externally published | Yes |